Germany mulls export ban on Novo Nordisk’s Ozempic amid global shortage of weight-loss drugs: report

The German drug regulator is in talks with lawmakers about ban on export of Novo Nordisk’s diabetes drug Ozempic if the current measures fail to create awareness about the drug

from mint - science https://ift.tt/y8AmSBY
https://ift.tt/8u3PRhA